2m 2m 2m 2m 2m 2m 2m
GRIFOLS SP ADR-B (GRFS)
NASDAQ
$7.58-$0.05 (-0.66%)
Price as of Jun 03, 2026 5:31 PM EDT- $5.3BMarket Cap
- -6.97%1-Year Change
- Drug Manufacturers - GeneralIndustry
GRIFOLS SP ADR-B (GRFS)
$7.58-$0.05 (-0.66%)
GRFS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.63 | ||
Change | -$0.11 (-1.42%) | ||
Open | $7.72 | ||
High | $7.78 | ||
Low | $7.61 | ||
Previous Close | $7.74 | ||
Volume | 583,189 | ||
30-Day Average Volume | 625,782 | ||
1-Week Change | -4.74% | ||
1-Month Change | -7.29% | ||
1-Year Change | -6.97% | ||
3-Year Change | -11.83% | ||
5-Year Change | -54.34% | ||
Fundamentals | |||
Shares Outstanding | 680.6M | ||
Total Assets | $19.7B | ||
Market Cap | $5.3B | ||
Enterprise Value | $4.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 08/12/2025 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 01/04/2016 | ||
Earnings & Revenue
Annual Dividend Yield